Standard treatment period: 600mg (morning: 300mg, evening: 300mg) When dose increased: 800mg (morning: 400mg, evening: 400mg)

2 trials

Sponsors

Shimane University Hospital

Conditions

mitochondrial fatty acid beta-oxidation disorders

Phase 2

The multicenter continuous clinical trial of the safety and efficacy of bezafibrate for mitochondrial fatty acid beta-oxidation disorders

Active, not recruitingJPRN-UMIN000016951

Shimane University Hospitalmitochondrial fatty acid beta-oxidation disorders

Start: 2015-01-01Target: 10Updated: 2026-06-29

The multicenter continuous clinical study on the safety of long-term administration of bezafibrate for mitochondrial fatty acid beta-oxidation disorders

Active, not recruitingJPRN-UMIN000017984

Shimane University Hospitalmitochondrial fatty acid beta-oxidation disorders

Start: 2015-08-01Target: 10Updated: 2026-06-29